HMGB1 and myeloid sarcoma: In MS, HMGB1 has been proposed as an important driver (83) with HMGB1 expression in MS lesions (84) and elevated serum levels of HMGB1 in treatment naïve MS patients, compared to those receiving disease-modifying treatment (85).